Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy China SXT Pharmaceuticals stock | $1.06

Learn how to easily invest in China SXT Pharmaceuticals stock.

China SXT Pharmaceuticals Inc is a drug manufacturers-specialty & generic business based in the US. China SXT Pharmaceuticals shares (SXTC) are listed on the NASDAQ and all prices are listed in US Dollars. China SXT Pharmaceuticals employs 96 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in China SXT Pharmaceuticals

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – SXTC – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

China SXT Pharmaceuticals stock price (NASDAQ: SXTC)

Use our graph to track the performance of SXTC stocks over time.

China SXT Pharmaceuticals shares at a glance

Information last updated 2021-10-16.
Latest market close$1.06
52-week range$0.89 - $5.12
50-day moving average $1.04
200-day moving average $1.29
Wall St. target priceN/A
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.19

Buy China SXT Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy China SXT Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

China SXT Pharmaceuticals price performance over time

Historical closes compared with the close of $1.06 from 2021-10-22

1 week (2021-10-15) 13.86%
1 month (2021-09-23) 0.95%
3 months (2021-07-23) -22.06%
6 months (2021-04-23) -25.35%
1 year (2020-10-23) -18.71%
2 years (2019-10-23) -75.69%
3 years (2018-10-19) N/A
5 years (2016-10-19) N/A

Is China SXT Pharmaceuticals under- or over-valued?

Valuing China SXT Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of China SXT Pharmaceuticals's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

China SXT Pharmaceuticals's EBITDA

China SXT Pharmaceuticals's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $424,668.

The EBITDA is a measure of a China SXT Pharmaceuticals's overall financial performance and is widely used to measure a its profitability.

China SXT Pharmaceuticals financials

Revenue TTM $4.8 million
Gross profit TTM $2.8 million
Return on assets TTM -4.88%
Return on equity TTM -21.67%
Profit margin -57.52%
Book value $1.03
Market capitalisation $14.4 million

TTM: trailing 12 months

Shorting China SXT Pharmaceuticals shares

There are currently 362,331 China SXT Pharmaceuticals shares held short by investors – that's known as China SXT Pharmaceuticals's "short interest". This figure is 24.4% down from 479,364 last month.

There are a few different ways that this level of interest in shorting China SXT Pharmaceuticals shares can be evaluated.

China SXT Pharmaceuticals's "short interest ratio" (SIR)

China SXT Pharmaceuticals's "short interest ratio" (SIR) is the quantity of China SXT Pharmaceuticals shares currently shorted divided by the average quantity of China SXT Pharmaceuticals shares traded daily (recently around 124941.72413793). China SXT Pharmaceuticals's SIR currently stands at 2.9. In other words for every 100,000 China SXT Pharmaceuticals shares traded daily on the market, roughly 2900 shares are currently held short.

However China SXT Pharmaceuticals's short interest can also be evaluated against the total number of China SXT Pharmaceuticals shares, or, against the total number of tradable China SXT Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case China SXT Pharmaceuticals's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 China SXT Pharmaceuticals shares in existence, roughly 20 shares are currently held short) or 0.0293% of the tradable shares (for every 100,000 tradable China SXT Pharmaceuticals shares, roughly 29 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against China SXT Pharmaceuticals.

Find out more about how you can short China SXT Pharmaceuticals stock.

China SXT Pharmaceuticals share dividends

We're not expecting China SXT Pharmaceuticals to pay a dividend over the next 12 months.

Have China SXT Pharmaceuticals's shares ever split?

China SXT Pharmaceuticals's shares were split on a 1:4 basis on 21 February 2021. So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your China SXT Pharmaceuticals shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for China SXT Pharmaceuticals shares which in turn could have impacted China SXT Pharmaceuticals's share price.

China SXT Pharmaceuticals share price volatility

Over the last 12 months, China SXT Pharmaceuticals's shares have ranged in value from as little as $0.89 up to $5.12. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while China SXT Pharmaceuticals's is -0.2246. This would suggest that China SXT Pharmaceuticals's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, China SXT Pharmaceuticals has bucked the trend.

China SXT Pharmaceuticals overview

China SXT Pharmaceuticals, Inc. , a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. It offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. The company provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. As of July 31, 2021, its end-customer base includes 70 pharmaceutical companies, 12 chain pharmacies, and 59 hospitals in 10 provinces and municipalities in China, including Jiangsu, Hubei, Shandong, Guangdong, Liaoning, Anhui, Henan, Jiangxi, Heilongjiang, and Hainan. The company was founded in 2005 and is based in Taizhou, China. .

Frequently asked questions

What percentage of China SXT Pharmaceuticals is owned by insiders or institutions?
Currently 20.386% of China SXT Pharmaceuticals shares are held by insiders and 1.064% by institutions.
How many people work for China SXT Pharmaceuticals?
Latest data suggests 96 work at China SXT Pharmaceuticals.
When does the fiscal year end for China SXT Pharmaceuticals?
China SXT Pharmaceuticals's fiscal year ends in March.
Where is China SXT Pharmaceuticals based?
China SXT Pharmaceuticals's address is: 178 North Taidong Road, Taizhou, China, 225300
What is China SXT Pharmaceuticals's ISIN number?
China SXT Pharmaceuticals's international securities identification number is: VGG2161P1163
What is China SXT Pharmaceuticals's CUSIP number?
China SXT Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: G2161P108

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site